Mechanical Conflict System: A Novel Operant Method for the Assessment of Nociceptive Behavior

A new operant test for preclinical pain research, termed the Mechanical Conflict System (MCS), is presented. Rats were given a choice either to remain in a brightly lit compartment or to escape to a dark compartment by crossing an array of height-adjustable nociceptive probes. Latency to escape the light compartment was evaluated with varying probe heights (0, .5, 1, 2, 3, and 4 mm above compartment floor) in rats with neuropathic pain induced by constriction nerve injury (CCI) and in naive control rats. Escape responses in CCI rats were assessed following intraperitoneal administration of pregabalin (10 and 30 mg/kg), morphine (2.5 and 5 mg/kg), and the tachykinin NK1 receptor antagonist, RP 67580 (1 and 10 mg/kg). Results indicate that escape latency increased as a function of probe height in both naive and CCI rats. Pregabalin (10 and 30 mg/kg) and morphine (5 mg/kg), but not RP 67580, decreased latency to escape in CCI rats suggesting an antinociceptive effect. In contrast, morphine (10 mg/kg) but not pregabalin (30 mg/kg) increased escape latency in naive rats suggesting a possible anxiolytic action of morphine in response to light-induced fear. No order effects following multiple test sessions were observed. We conclude that the MCS is a valid method to assess behavioral signs of affective pain in rodents.

[1]  F. Moss Study of Animal Drives. , 1924 .

[2]  L. Warner A study of hunger behavior in the white rat by means of the obstruction method. Comparison of sex an , 1928 .

[3]  C. Warden,et al.  An experimental analysis of the obstruction method of measuring animal drives. , 1928 .

[4]  A New Obstruction Box , 1939 .

[5]  S. Irwin,et al.  The effects of morphine methadone and meperidine on some reflex responses of spinal animals to nociceptive stimulation. , 1951, The Journal of pharmacology and experimental therapeutics.

[6]  B. Campbell,et al.  Punishment and aversive behavior , 1969 .

[7]  J. Marshall THE SKIN SENSES , 1969 .

[8]  F. E. Grubbs Procedures for Detecting Outlying Observations in Samples , 1969 .

[9]  B. Weiner Human Motivation: Metaphors, Theories, and Research , 1980 .

[10]  Richard Grossman,et al.  The animals , 1983 .

[11]  M. Papp,et al.  Separation of the motivational and motor consequences of 6-hydroxydopamine lesions of the mesolimbic or nigrostriatal system in rats , 1987, Behavioural Brain Research.

[12]  Gary J. Bennett,et al.  A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man , 1988, Pain.

[13]  K. Franklin,et al.  Techniques for Assessing the Effects of Drugs on Nociceptive Responses , 1989 .

[14]  P. Laduron,et al.  Pharmacological properties of a potent and selective nonpeptide substance P antagonist. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[15]  G. Borszcz,et al.  Characterization of tailshock elicited withdrawal reflexes in intact and spinal rats , 1992, Physiology & Behavior.

[16]  C. Strader,et al.  Molecular basis for the species selectivity of the neurokinin-1 receptor antagonists CP-96,345 and RP67580. , 1992, The Journal of biological chemistry.

[17]  M. Heinricher,et al.  Activity of neurons in the rostral medulla of the halothane-anesthetized rat during withdrawal from noxious heat , 1992, Brain Research.

[18]  A. Eschalier,et al.  RP-67580, a specific tachykinin NK1 receptor antagonist, relieves chronic hyperalgesia in diabetic rats. , 1993, European journal of pharmacology.

[19]  S. Iversen,et al.  Antinociceptive activity of NK1 receptor antagonists: non‐specific effects of racemic RP67580 , 1993, British journal of pharmacology.

[20]  J. Glowinski,et al.  Higher potency of RP 67580, in the mouse and the rat compared with other nonpeptide and peptide tachykinin NK1 antagonists , 1993, British journal of pharmacology.

[21]  S. H. Kim,et al.  Effects of sympathectomy on a rat model of peripheral neuropathy , 1993, Pain.

[22]  R. Hargreaves,et al.  Effect of RP 67580, a non‐peptide neurokinin1 receptor antagonist, on facilitation of a nociceptive spinal flexion reflex in the rat , 1993, British journal of pharmacology.

[23]  W D Willis,et al.  Cutaneous sensory receptors in the rat foot. , 1993, Journal of neurophysiology.

[24]  J. Chung,et al.  Abnormalities of mechanoreceptors in a rat model of neuropathic pain: possible involvement in mediating mechanical allodynia. , 1993, Journal of neurophysiology.

[25]  J. Chung,et al.  Signs of neuropathic pain depend on signals from injured nerve fibers in a rat model , 1993, Brain Research.

[26]  J. Besson,et al.  Physiological contributions of neurokinin 1 receptor activation, and interactions with NMDA receptors, to inflammatory-evoked spinal c-Fos expression. , 1996, Journal of neurophysiology.

[27]  C. Woolf,et al.  Tachykinin NK1 receptor antagonist RP67580 attenuates progressive hypersensitivity of flexor reflex during experimental inflammation in rats. , 1997, European journal of pharmacology.

[28]  C. Dourish,et al.  Behavioural and pharmacological characterisation of the canopy stretched attend posture test as a model of anxiety in mice and rats , 1997, Psychopharmacology.

[29]  C. Woolf,et al.  Morphine, the NMDA receptor antagonist MK801 and the tachykinin NK1 receptor antagonist RP67580 attenuate the development of inflammation-induced progressive tactile hypersensitivity , 1998, Pain.

[30]  D. Ardid,et al.  Amygdala Lesions Produce Analgesia in a Novel, Ethologically Relevant Acute Pain Test , 1999, Physiology & Behavior.

[31]  S. Morato,et al.  A comparative study of the effects of morphine in the dorsal periaqueductal gray and nucleus accumbens of rats submitted to the elevated plus-maze test , 1999, Experimental Brain Research.

[32]  R Hill,et al.  NK1 (substance P) receptor antagonists--why are they not analgesic in humans? , 2000, Trends in pharmacological sciences.

[33]  P. Fuchs,et al.  Morphine and gabapentin decrease mechanical hyperalgesia and escape/avoidance behavior in a rat model of neuropathic pain , 2000, Neuroscience Letters.

[34]  C. Vierck,et al.  An operant assay of thermal pain in conscious, unrestrained rats , 2000, Journal of Neuroscience Methods.

[35]  P. Fuchs,et al.  A Behavioral Test Paradigm to Measure the Aversive Quality of Inflammatory and Neuropathic Pain in Rats , 2000, Experimental Neurology.

[36]  A. Eschalier,et al.  Evidence for an involvement of tachykinins in allodynia in streptozocin-induced diabetic rats. , 2000, European journal of pharmacology.

[37]  S. Iyengar,et al.  Dose-Response Study of the Analgesic Effect of Lanepitant in Patients with Painful Diabetic Neuropathy , 2001, Clinical neuropharmacology.

[38]  M. J. Field,et al.  Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity , 2001, British journal of pharmacology.

[39]  T. Morrow,et al.  Long-term changes in behavior and regional cerebral blood flow associated with painful peripheral mononeuropathy in the rat , 2002, Pain.

[40]  R. Poole,et al.  Pregabalin for the treatment of postherpetic neuralgia , 2003, Neurology.

[41]  Hans Peter Kaesermann,et al.  Stretched attend posture, a non-social form of ambivalence, is sensitive to a conflict-reducing drug action , 2004, Psychopharmacology.

[42]  B. Beer,et al.  A simple and reliable conflict procedure for testing anti-anxiety agents , 2004, Psychopharmacologia.

[43]  Effects of chlordiazepoxide, pentobarbital, buspirone, chlorpromazine, and morphine in the stretched attend posture (SAP) test , 2004, Psychopharmacology.

[44]  Dante R. Chialvo,et al.  Chronic pain patients are impaired on an emotional decision-making task , 2004, Pain.

[45]  J. Mogil,et al.  What should we be measuring in behavioral studies of chronic pain in animals? , 2004, Pain.

[46]  R. H. Silva,et al.  Effects of morphine on the plus-maze discriminative avoidance task: role of state-dependent learning , 2005, Psychopharmacology.

[47]  D. Borsook,et al.  Behavioral and pharmacological characterization of a distal peripheral nerve injury in the rat , 2005, Pharmacology Biochemistry and Behavior.

[48]  D. Chialvo,et al.  Spared nerve injury rats exhibit thermal hyperalgesia on an automated operant dynamic thermal escape Task , 2005, Molecular pain.

[49]  C. Vierck,et al.  Use of a novel thermal operant behavioral assay for characterization of orofacial pain sensitivity , 2005, Pain.

[50]  Dante R Chialvo,et al.  Inflammatory and neuropathic pain animals exhibit distinct responses to innocuous thermal and motoric challenges , 2006, Molecular pain.

[51]  D. Borsook,et al.  Preclinical Assessment of Candidate Analgesic Drugs: Recent Advances and Future Challenges , 2006, Journal of Pharmacology and Experimental Therapeutics.

[52]  N. Yonehara,et al.  Alteration in sensitivity of ionotropic glutamate receptors and tachykinin receptors in spinal cord contribute to development and maintenance of nerve injury-evoked neuropathic pain , 2006, Neuroscience Research.

[53]  S. Donevan,et al.  Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission. , 2007, Trends in pharmacological sciences.

[54]  S. Donevan,et al.  Ca2+ channel α2δ ligands: novel modulators of neurotransmission , 2007 .

[55]  J. Zohar,et al.  Brief post-stressor treatment with pregabalin in an animal model for PTSD: Short-term anxiolytic effects without long-term anxiogenic effect , 2008, European Neuropsychopharmacology.

[56]  C. Vierck,et al.  Clinical and pre-clinical pain assessment: Are we measuring the same thing? , 2008, PAIN®.

[57]  Rolf-Detlef Treede,et al.  Anxiety-like behaviour in rats with mononeuropathy is reduced by the analgesic drugs morphine and gabapentin , 2008, PAIN.

[58]  L. Leventhal,et al.  Predictive validity of animal pain models? A comparison of the pharmacokinetic–pharmacodynamic relationship for pain drugs in rats and humans , 2008, Neuropharmacology.

[59]  Andrew S.C. Rice,et al.  Anxiety-like behaviour is attenuated by gabapentin, morphine and diazepam in a rodent model of HIV anti-retroviral-associated neuropathic pain , 2008, Neuroscience Letters.

[60]  M. Max,et al.  The molecular epidemiology of pain: a new discipline for drug discovery , 2008, Nature Reviews Drug Discovery.

[61]  Louis P. Vera-Portocarrero,et al.  Unmasking the tonic-aversive state in neuropathic pain , 2009, Nature Neuroscience.

[62]  R. Treede,et al.  Effect of high trait anxiety on mechanical hypersensitivity in male rats , 2009, Neuroscience Letters.

[63]  P. Wiffen,et al.  Pregabalin for acute and chronic pain in adults. , 2009, The Cochrane database of systematic reviews.

[64]  V. Galhardo,et al.  Cognitive impairment of prefrontal-dependent decision-making in rats after the onset of chronic pain , 2009, Neuroscience.

[65]  Glenn W. Stevenson,et al.  Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice. , 2009, Life sciences.

[66]  J. Mogil Animal models of pain: progress and challenges , 2009, Nature Reviews Neuroscience.

[67]  R. Depoortère,et al.  Comparison of milnacipran, duloxetine and pregabalin in the formalin pain test and in a model of stress-induced ultrasonic vocalizations in rats , 2010, Neuroscience Research.

[68]  T. Morrow,et al.  Pregabalin modulates motivational but not sensory pain behaviors in rats with peripheral nerve injury , 2010 .

[69]  J. DeJongh,et al.  Pharmacokinetic–Pharmacodynamic Analysis of the Static Allodynia Response to Pregabalin and Sildenafil in a Rat Model of Neuropathic Pain , 2010, Journal of Pharmacology and Experimental Therapeutics.

[70]  T. Jensen,et al.  Pregabalin attenuates place escape/avoidance behavior in a rat model of spinal cord injury , 2011, Brain Research.

[71]  D. Chialvo,et al.  Altered associative learning and emotional decision making in fibromyalgia. , 2011, Journal of psychosomatic research.

[72]  Loren J. Martin,et al.  The Rat Grimace Scale: A partially automated method for quantifying pain in the laboratory rat via facial expressions , 2011, Molecular pain.

[73]  O. Gunduz,et al.  Pharmacological and behavioral characterization of the saphenous chronic constriction injury model of neuropathic pain in rats , 2011, Neurological Sciences.

[74]  R. Caudle,et al.  Adaptation of a novel operant orofacial testing system to characterize both mechanical and thermal pain , 2011, Behavioural Brain Research.

[75]  Tatsuo Yamamoto,et al.  The Efficacy of Morphine, Pregabalin, Gabapentin, and Duloxetine on Mechanical Allodynia Is Different from That on Neuroma Pain in the Rat Neuropathic Pain Model , 2012, Anesthesia and analgesia.

[76]  P. Fuchs,et al.  The place escape/avoidance paradigm: a novel method to assess nociceptive processing. , 2012, Journal of integrative neuroscience.

[77]  A. Eschalier,et al.  Study of emotional and cognitive impairments in mononeuropathic rats: Effect of duloxetine and gabapentin , 2012, PAIN®.

[78]  T. Morrow,et al.  Herpes Simplex Virus Vector–Mediated Expression of Interleukin-10 Reduces Below-Level Central Neuropathic Pain After Spinal Cord Injury , 2012, Neurorehabilitation and neural repair.

[79]  C. Woolf,et al.  Inflammation-induced decrease in voluntary wheel running in mice: A nonreflexive test for evaluating inflammatory pain and analgesia , 2012, PAIN®.

[80]  Jianren Mao,et al.  Current challenges in translational pain research. , 2012, Trends in pharmacological sciences.

[81]  A novel operant method to test acute heat hypersensitivity in mice using a modification of the Coy Operant Mechanical Conflict Avoidance System , 2013 .

[82]  P. Dougherty,et al.  An overview of animal models of pain: disease models and outcome measures. , 2013, The journal of pain : official journal of the American Pain Society.

[83]  Patrick F. Rock,et al.  Sensitivity , 2014, Radiopaedia.org.

[84]  Chourouk Mzahi Reshaping the Village Test for investigating service brand attachment , 2014 .

[85]  N. Nishiyama,et al.  Memory Impairment and Reduced Exploratory Behavior in Mice after Administration of Systemic Morphine , 2015, Journal of experimental neuroscience.

[86]  Julian Taylor,et al.  Early treatment with UR13870, a novel inhibitor of p38α mitogenous activated protein kinase, prevents hyperreflexia and anxiety behaviors, in the spared nerve injury model of neuropathic pain , 2015, Neuroscience Letters.

[87]  C. Vierck,et al.  Comparison of operant escape and reflex tests of nociceptive sensitivity , 2015, Neuroscience & Biobehavioral Reviews.